道诺霉素（CAS 20830-81-3）：分子式 C27H29NO10、分子量 527.5。
| CAS号 | 20830-81-3 |
|---|---|
| 分子式 | C27H29NO10 |
| 分子量 | 527.5 |
| 熔点 | 208-209 °C |
| 沸点 | 190 |
| LogP | 1.83 |
| 应用领域 | Uses: An anti-mitotic agent used in cancer chemotherapy、[HSDB]、Antimitotic agent in cancer chemotherapy (non-USA use).、Therapeutic Category: Antineoplastic、MEDICATION、For remission induction in acute nonlymphocytic leukemia (myelogenous、monocytic、erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.、Methods of Manufacturing: Isolated from fermentation broths of Streptomyces peucetius.、Daunorubicin is obtained from cultures of Streptomyces caeruleorubidus and Streptomyces peucetius、which occur in soil.、Impurities: Daunorubicinone、Daunorubicinol、13-dihydrodaunorubicinone、Doxorubicin、For more Impurities (Complete) data for DAUNORUBICIN (6 total)、please visit the HSDB record page.、Formulations、Preparations: Acetyladriamycin、Cerubidin、Cerubidine、Daunoblastina、Ondena.、Daunorubicin hydrochloride、.、Daunarubicinum、For more Formulations、Preparations (Complete) data for DAUNORUBICIN (19 total)、U.S. Production: (1977) Not produced commercially in USA、(1979) Not produced commercially in USA、General Manufacturing Information: Daunorubicin is a glycoside formed by a tetracyclic aglycone、daunomycinone、and an amino sugar、daunosamine、3-amino-2、3、6-trideoxy-l-lyxo-hexose. |
登记用途：Uses: An anti-mitotic agent used in cancer chemotherapy、[HSDB]、Antimitotic agent in cancer chemotherapy (non-USA use).、Therapeutic Category: Antineoplastic、MEDICATION、For remission induction in acute nonlymphocytic leukemia (myelogenous、monocytic、erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.、Methods of Manufacturing: Isolated from fermentation broths of Streptomyces peucetius.、Daunorubicin is obtained from cultures of Streptomyces caeruleorubidus and Streptomyces peucetius、which occur in soil.、Impurities: Daunorubicinone、Daunorubicinol、13-dihydrodaunorubicinone、Doxorubicin、For more Impurities (Complete) data for DAUNORUBICIN (6 total)、please visit the HSDB record page.、Formulations、Preparations: Acetyladriamycin、Cerubidin、Cerubidine、Daunoblastina、Ondena.、Daunorubicin hydrochloride、.、Daunarubicinum、For more Formulations、Preparations (Complete) data for DAUNORUBICIN (19 total)、U.S. Production: (1977) Not produced commercially in USA、(1979) Not produced commercially in USA、General Manufacturing Information: Daunorubicin is a glycoside formed by a tetracyclic aglycone、daunomycinone、and an amino sugar、daunosamine、3-amino-2、3、6-trideoxy-l-lyxo-hexose.。
道诺霉素 是一种化工化合物，登记 CAS 号为 20830-81-3，分子式 C27H29NO10（分子量 527.5）。
登记 CAS 号：20830-81-3
其分子式 C27H29NO10 由 27 个碳、29 个氢、1 个氮、10 个氧 组成。
别名/同义词：道诺霉素 · Daunomycin
道诺霉素 的 CAS 登记号为 20830-81-3。
分子式 C27H29NO10，分子量 527.5。
别名/同义词：道诺霉素、Daunomycin。
登记用途：Uses: An anti-mitotic agent used in cancer chemotherapy、[HSDB]、Antimitotic agent in cancer chemotherapy (non-USA use).、Therapeutic Category: Antineoplastic、MEDICATION、For remission induction in acute nonlymphocytic leukemia (myelogenous、monocytic、erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.、Methods of Manufacturing: Isolated from fermentation broths of Streptomyces peucetius.、Daunorubicin is obtained from cultures of Streptomyces caeruleorubidus and Streptomyces peucetius、which occur in soil.、Impurities: Daunorubicinone、Daunorubicinol、13-dihydrodaunorubicinone、Doxorubicin、For more Impurities (Complete) data for DAUNORUBICIN (6 total)、please visit the HSDB record page.、Formulations、Preparations: Acetyladriamycin、Cerubidin、Cerubidine、Daunoblastina、Ondena.、Daunorubicin hydrochloride、.、Daunarubicinum、For more Formulations、Preparations (Complete) data for DAUNORUBICIN (19 total)、U.S. Production: (1977) Not produced commercially in USA、(1979) Not produced commercially in USA、General Manufacturing Information: Daunorubicin is a glycoside formed by a tetracyclic aglycone、daunomycinone、and an amino sugar、daunosamine、3-amino-2、3、6-trideoxy-l-lyxo-hexose.。
道诺霉素（CAS 20830-81-3）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 20830-81-3 |
|---|---|
| PubChem CID | 30323 |
| Molecular formula | C27H29NO10 |
| IUPAC name | (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| UNII (FDA) | ZS7284E0ZP |
| Molecular Weight | 527.5 |
|---|---|
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 4 |
| Exact Mass | 527.17914612 |
| Monoisotopic Mass | 527.17914612 |
| Topological Polar Surface Area | 186 |
| Heavy Atom Count | 38 |
| Boiling Point | 190 |
|---|---|
| Boiling Point | 190 °C, decomposes |
| Melting Point | 208-209 °C |
| Melting Point | 208 - 209 °C |
| Solubility | 30000 |
| Solubility | In water, 3.0X10+4 mg/L at 25 °C |
| Solubility | 6.27e-01 g/L |
| Vapor Pressure | 9.4X10-15 mm Hg at 25 °C |
| LogP | 1.83 |
| LogP | log Kow = 1.83 |
daunorubicin; Daunomycin; 20830-81-3; Acetyladriamycin; Leukaemomycin C; Daunorubicine; Rubidomycin; (+)-Daunomycin; Rubomycin C; Daunarubicinum; Daunorrubicina; Daunamycin; Daunorubicinum; Cerubidin; RP 13057; FI6339
| Reported hazard statements | H301 (100%), H341 (100%), H351 (100%), H361 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H341 (100%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]
Daunomycin · CAS 20830-81-3 · C27H29NO10. UNII ZS7284E0ZP. Boiling Point: 190; Boiling Point: 190 °C, decomposes; Melting Point: 208-209 °C.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Daunomycin